Literature DB >> 1379594

Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3.

D M Ornitz1, P Leder.   

Abstract

The heparin-binding growth factors include a family of seven structurally related proteins that can potentially interact with four known high affinity receptors. We have cloned the murine homologues of fibroblast growth factor receptors 1 and 3 (mFR1 and mFR3). To define the ligand specificity of these receptors, we have characterized their binding properties with respect to acidic and basic fibroblast growth factors (aFGF and bFGF, respectively) and their biologic activity with respect to aFGF, bFGF, FGF-4/K-FGF, and FGF-5. Unlike mFR1, which binds both aFGF and bFGF, mFR3 preferentially binds aFGF. mFR3-mediated mitogenicity also favors aFGF and FGF-4 with a 10-12-fold lower response to bFGF and no response to FGF-5. Both receptor binding and growth factor-mediated mitogenicity are dependent on heparin. Heparin-binding growth factor activity can thus be regulated by proteoglycans and by the type of FGF receptor expressed on the target cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379594

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  A role for fibroblast growth factor signaling in the lobuloalveolar development of the mammary gland.

Authors:  D Jackson; J Bresnick; C Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

Authors:  M Chesi; E Nardini; L A Brents; E Schröck; T Ried; W M Kuehl; P L Bergsagel
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

3.  Structure Activity Relationship of Heparin Mimicking Polymer p(SS-co-PEGMA): Effect of Sulfonation and Polymer Size on FGF2-Receptor Binding.

Authors:  Samantha J Paluck; Heather D Maynard
Journal:  Polym Chem       Date:  2017-07-05       Impact factor: 5.582

4.  Cloning and interspecies comparisons of three newt (Notophthalmus viridescens) fibroblast growth factor receptor sequences.

Authors:  M L Poulin; M J Botelho; I M Chiu
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

Review 5.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

6.  Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.

Authors:  G Yan; Y Fukabori; G McBride; S Nikolaropolous; W L McKeehan
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients.

Authors:  S Ikegawa; Y Fukushima; M Isomura; F Takada; Y Nakamura
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

8.  A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.

Authors:  A Superti-Furga; G Eich; H U Bucher; J Wisser; A Giedion; R Gitzelmann; B Steinmann
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

9.  High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.

Authors:  H G Cheon; W J LaRochelle; D P Bottaro; W H Burgess; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.

Authors:  Jedrzej Małecki; Jørgen Wesche; Camilla Skiple Skjerpen; Antoni Wiedłocha; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.